Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Orteq
company
About
Orteq is a medical device company that develops and commercializes bioengineering solutions for orthopaedic injuries.
- 501 - 1000
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- £8M
- Industries
- Biotechnology,Health Care,Manufacturing,Medical,Medical Device,Sports,Wellness
- Founded date
- Jan 1, 2005
- Number Of Employee
- 501 - 1000
- Operating Status
- Active
Orteq was established in 2005 to develop and commercialize bioengineering solutions for orthopaedic injuries. Orteq has developed a biodegradable, biocompatible polymer implant, Actifit, specifically designed to promote tissue ingrowth and regeneration in the meniscus, a fibrocartilage cushion in the knee. The company develops innovative healthcare products for the arthroscopic sports medicine surgeon that encourage the body’s own natural healing process.Orteq is headquartered in London.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
£8M
Orteq has raised a total of
£8M
in funding over 2 rounds. Their latest funding was raised on
Oct 7, 2008 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 7, 2008 | Series B | £8M | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Orteq is funded by 1 investors.
Matignon Technologies
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
